Ultromics Company
They are building world-class diagnostic aids to help cardiologists вАФ powered by artificial intelligence. To date, they have developed the worldвАЩs most accurate echocardiography software to improve the diagnosis of coronary heart disease by more than 90%.
Investors
%20.png)
Last Funding Type:
Series B
Funding Status:
Early Stage Venture
Headquarters:
Oxford, Oxfordshire, United Kingdom
Founded Date:
2017-01-01
Last Funding Date:
2021-08-16
Total Funding:
58824943
Technology:
HealthCare Administration
Employee Number:
11-50
Estimated Revenue:
$1M to $10M
Investors Number:
13
Industry:
Imaging